En español

Director's Page

NIDA Director, Dr. Nora D. Volkow

Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. NIDA supports most of the world’s research on the health aspects of drug abuse and addiction.

Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the use of brain imaging to investigate the toxic effects and addictive properties of abusable drugs. Her studies have documented changes in the dopamine system affecting, among others, the functions of frontal brain regions involved with motivation, drive, and pleasure in addiction.  She has also made important contributions to the neurobiology of obesity, ADHD, and aging. Read more.

Cover of Nature issue  on Addiction

Read about the latest advances in addiction research in Nature Outlook: Addiction, a special supplement co-sponsored by NIDA and NIAAA. View the entire supplement at: http://www.nature.com/nature/outlook/addiction/. For a commentary authored by NIDA Director Dr. Nora D. Volkow and NIAAA Director Dr. George F. Koob, go to http://www.nature.com/nature/outlook/addiction/
pdf/NIDA_NIH.pdf (PDF,108KB)

Cover of Lancet journal

The brain disease model of addiction is strongly supported by scientific evidence, according to a commentary - “Brain disease model of addiction: why is it so controversial?” , published in The Lancet Psychiatry by NIDA Director Dr. Nora Volkow and NIAAA Director Dr. George Koob.

Get this Publication

Receive Nora’s Blog Articles in your Email!
You will only receive messages related to Nora’s Blog

Dr. Nora Volkow: Video Highlights

NIDA Director, Dr. Nora D. Volkow Videos

Interviews with NIDA Scientists

2011 Society for Neuroscience meeting

NIDA scientists and grantees bring brain science to life in these video interviews conducted at NIDA's 2011 Frontiers in Science mini convention at the Society for Neuroscience meeting in Washington, D.C.